Cristofanilli M - Search Results

1

Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Cristofanilli M. Cristofanilli M. Semin Oncol. 2006 Jun;33(3 Suppl 9):S9-14. doi: 10.1053/j.seminoncol.2006.03.016. Semin Oncol. 2006. PMID: 16797376 Review.

2

Phase II study of adozelesin in untreated metastatic breast cancer.

Cristofanilli M, Bryan WJ, Miller LL, Chang AY, Gradishar WJ, Kufe DW, Hortobagyi GN. Cristofanilli M, et al. Anticancer Drugs. 1998 Oct;9(9):779-82. doi: 10.1097/00001813-199810000-00006. Anticancer Drugs. 1998. PMID: 9840723 Clinical Trial.

3

Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience.

Cristofanilli M, Holmes FA, Esparza L, Valero V, Buzdar AU, Neidhart JA, Hortobagyi GN. Cristofanilli M, et al. Breast Cancer Res Treat. 1999 Apr;54(3):225-33. doi: 10.1023/a:1006104610727. Breast Cancer Res Treat. 1999. PMID: 10445421 Clinical Trial.

4

Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy.

Buchholz TA, Tucker SL, Erwin J, Mathur D, Strom EA, McNeese MD, Hortobagyi GN, Cristofanilli M, Esteva FJ, Newman L, Singletary SE, Buzdar AU, Hunt KK. Buchholz TA, et al. Among authors: cristofanilli m. J Clin Oncol. 2001 Apr 15;19(8):2240-6. doi: 10.1200/JCO.2001.19.8.2240. J Clin Oncol. 2001. PMID: 11304777

5

New horizons in treating metastatic disease.

Cristofanilli M, Hortobagyi GN. Cristofanilli M, et al. Clin Breast Cancer. 2001 Jan;1(4):276-87. doi: 10.3816/CBC.2001.n.002. Clin Breast Cancer. 2001. PMID: 11899350 Review.

6

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer.

Esteva FJ, Valero V, Booser D, Guerra LT, Murray JL, Pusztai L, Cristofanilli M, Arun B, Esmaeli B, Fritsche HA, Sneige N, Smith TL, Hortobagyi GN. Esteva FJ, et al. Among authors: cristofanilli m. J Clin Oncol. 2002 Apr 1;20(7):1800-8. doi: 10.1200/JCO.2002.07.058. J Clin Oncol. 2002. PMID: 11919237 Clinical Trial.

7

Molecular prognostic factors for breast cancer metastasis and survival.

Esteva FJ, Sahin AA, Cristofanilli M, Arun B, Hortobagyi GN. Esteva FJ, et al. Among authors: cristofanilli m. Semin Radiat Oncol. 2002 Oct;12(4):319-28. doi: 10.1053/srao.2002.35251. Semin Radiat Oncol. 2002. PMID: 12382190 Review.

8

Update on the management of inflammatory breast cancer.

Cristofanilli M, Buzdar AU, Hortobágyi GN. Cristofanilli M, et al. Oncologist. 2003;8(2):141-8. doi: 10.1634/theoncologist.8-2-141. Oncologist. 2003. PMID: 12697939 Free article. Review.

9

Chest wall recurrence after mastectomy does not always portend a dismal outcome.

Chagpar A, Meric-Bernstam F, Hunt KK, Ross MI, Cristofanilli M, Singletary SE, Buchholz TA, Ames FC, Marcy S, Babiera GV, Feig BW, Hortobagyi GN, Kuerer HM. Chagpar A, et al. Among authors: cristofanilli m. Ann Surg Oncol. 2003 Jul;10(6):628-34. doi: 10.1245/aso.2003.01.004. Ann Surg Oncol. 2003. PMID: 12839847

10

A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer.

Trent JC, Valero V, Booser DJ, Esparza-Guerra LT, Ibrahim N, Rahman Z, Vernillet L, Patel S, David CL, Murray JL, Cristofanilli M, Hortobagyi GN. Trent JC, et al. Among authors: cristofanilli m. Clin Cancer Res. 2003 Jul;9(7):2426-34. Clin Cancer Res. 2003. PMID: 12855614 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

468 results

Search Page

Filters